Back to results
US 2007/0167373 A1Published application
Combined use of a GLP-1 compound and a modulator of diabetic late complications
AssigneeNovo Nordisk A/S
InventorsLotte Knudsen, Johan Selmer
Life of this patent
Estimating the term…
Abstract
Methods and uses for treatment of diabetic late complications comprising administration of a GLP-1 compound and a modulator of diabetic complications.
Claims20
A method for treating diabetic late complications in a patient in need thereof, said method comprising administration to said patient of an effective amount of a glucagon-like peptide 1 (GLP-1) compound and an effective amount of a modulator of a diabetic late complication.
Dependencies are inferred from the claim text.